N-(Phenylacetyl)-L-alanine → N-[N-(Phenylacetyl)-L-alaninyl]-L-isoleucine Methyl Ester

HRID 322776

Reaktionsgleichung

Reaktionsgleichung von HRID 322776
[C:1]1([CH2:7][C:8]([NH:10][C@H:11]([C:13]([OH:15])=O)[CH3:12])=[O:9])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.Cl.[CH3:17][O:18][C:19](=[O:26])[C@H:20]([C@H:22]([CH2:24][CH3:25])[CH3:23])[NH2:21]>>[CH3:17][O:18][C:19](=[O:26])[C@H:20]([C@H:22]([CH2:24][CH3:25])[CH3:23])[NH:21][C:13](=[O:15])[C@H:11]([CH3:12])[NH:10][C:8](=[O:9])[CH2:7][C:1]1[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=1

Komponenten

3

Versuchsvorschrift

Following General Procedure A and using N-(phenylacetyl)-L-alanine (from Example B1 above) and L-isoleucine methyl ester hydrochloride (Sigma), the title compound was prepared. The reaction was monitored by tlc (Rf=0.24 in 50% EtOAc/hexanes).

Quellen und Nachweise

ORD-Eintrag
ord-b1c16b89c1f847eeb6db6966f07fd65a
Quelldatensatz
uspto-grants-2001_04
Patentnummer
US06211235B1

Verknüpfte Notizen

Wird geladen…